Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC)

Neoplasia

Volumn 10, Issue 5, 2008, Pages 462-470

  Sticht, Carsten ^a,b   Freier, Kolja ^a,b   Knöpfle, Karl ^a,b   Flechtenmacher, Christa ^b   Pungs, Susanne ^b   Hofele, Christof ^b   Hahn, Meinhard ^a   Joos, Stefan ^a   Lichter, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CANCER STAGING; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MOUTH CARCINOMA; MOUTH MUCOSA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

EID: 43249112539     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.08164     Document Type: Article

References (51)

1. GF Funk LH Karnell RA Robinson WK Zhen DK Trask HT Hoffman Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report Head Neck 24 2002 165 180
2. MA Weinberg DJ Estefan Assessing oral malignancies Am Fam Physician 65 2002 1379 1384
3. A Jemal T Murray A Samuels A Ghafoor E Ward MJ Thun Cancer statistics, 2003 CA Cancer J Clin 53 2003 5 26
4. C Sticht C Hofele C Flechtenmacher FX Bosch K Freier P Lichter S Joos Amplification of cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC) Br J Cancer 92 2005 770 774
5. JP Rodrigo PS Lazo S Ramos I Alvarez C Suarez MYC amplification in squamous cell carcinomas of the head and neck Arch Otolaryngol Head Neck Surg 122 1996 504 507
6. M Miyaguchi J Olofsson HB Hellquist Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma Acta Otolaryngol 110 1990 309 313
7. JO Boyle J Hakim W Koch P van der Riet RH Hruban RA Roa R Correo YJ Eby JM Ruppert D Sidransky The incidence of p53 mutations increases with progression of head and neck cancer Cancer Res 53 1993 4477 4480
8. CL Nutt DR Mani RA Betensky P Tamayo JG Cairncross C Ladd U Pohl C Hartmann ME McLaughlin TT Batchelor Gene expression-based classification of malignant gliomas correlates better with survival than histological classification Cancer Res 63 2003 1602 1607
9. AA Alizadeh MB Eisen RE Davis C Ma IS Lossos A Rosenwald JC Boldrick H Sabet T Tran X Yu Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511
10. KD Dahlquist N Salomonis K Vranizan SC Lawlor BR Conklin GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways Nat Genet 31 2002 19 20
11. M Ashburner CA Ball JA Blake D Botstein H Butler JM Cherry AP Davis K Dolinski SS Dwight JT Eppig Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat Genet 25 2000 25 29
12. SW Doniger N Salomonis KD Dahlquist K Vranizan SC Lawlor BR Conklin MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data Genome Biol 4 2003 R7
13. J van den Boom M Wolter R Kuick DE Misek AS Youkilis DS Wechsler C Sommer G Reifenberger SM Hanash Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction Am J Pathol 163 2003 1033 1043
14. J Schlingemann O Thuerigen C Ittrich G Toedt H Kramer M Hahn P Lichter Effective transcriptome amplification for expression profiling on sense-oriented oligonucleotide microarrays Nucleic Acids Res 33 2005 e29
15. B Tews J Felsberg C Hartmann A Kunitz M Hahn G Toedt K Neben L Hummerich A von Deimling G Reifenberger Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling Int J Cancer 119 2006 792 800
16. C Korz A Pscherer A Benner D Mertens C Schaffner E Leupolt H Dohner S Stilgenbauer P Lichter Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes Blood 99 2002 4554 4561
17. C Schwaenen M Nessling S Wessendorf T Salvi G Wrobel B Radlwimmer HA Kestler C Haslinger S Stilgenbauer H Dohner Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations Proc Natl Acad Sci USA 101 2004 1039 1044
18. K Freier FX Bosch C Flechtenmacher F Devens A Benner P Lichter S Joos C Hofele Distinct site-specific oncoprotein overexpression in head and neck squamous cell carcinoma: a tissue microarray analysis Anticancer Res 23 2003 3971 3977
19. RK O’Donnell M Kupferman SJ Wei S Singhal R Weber B O’Malley Y Cheng M Putt M Feldman B Ziober Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity Oncogene 24 2005 1244 1251
20. M Nagata H Fujita H Ida H Hoshina T Inoue Y Seki M Ohnishi T Ohyama S Shingaki M Kaji Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis Int J Cancer 106 2003 683 689
21. PD Karp M Riley SM Paley A Pellegrini-Toole The MetaCyc database Nucleic Acids Res 30 2002 59 61
22. P Grosu JP Townsend DL Hartl D Cavalieri Pathway processor: a tool for integrating whole-genome expression results into metabolic networks Genome Res 12 2002 1121 1126
23. AC Luyf J de Gast AH van Kampen Visualizing metabolic activity on a genome-wide scale Bioinformatics 18 2002 813 818
24. C Zucchini M Bianchini L Valvassori S Perdichizzi S Benini MC Manara R Solmi P Strippoli P Picci P Carinci Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene Bone 34 2004 672 679
25. TP Garrington GL Johnson Organization and regulation of mitogenactivated protein kinase signaling pathways Curr Opin Cell Biol 11 1999 211 218
26. Y Kato RI Tapping S Huang MH Watson RJ Ulevitch JD Lee Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor Nature 395 1998 713 716
27. S Kalyankrishna JR Grandis Epidermal growth factor receptor biology in head and neck cancer J Clin Oncol 24 2006 2666 2672
28. Y Tsuboi T Ichida S Sugitani T Genda J Inayoshi M Takamura Y Matsuda M Nomoto Y Aoyagi Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma Liver Int 24 2004 432 436
29. A Jinawath Y Akiyama Y Yuasa C Pairojkul Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma J Cancer Res Clin Oncol 132 2006 805 810
30. K Milde-Langosch AM Bamberger G Rieck D Grund G Hemminger V Muller T Loning Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer Br J Cancer 92 2005 2206 2215
31. S Vicent JM Lopez-Picazo G Toledo MD Lozano W Torre C Garcia-Corchon C Quero JC Soria S Martin-Algarra RG Manzano ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours Br J Cancer 90 2004 1047 1052
32. CC Bancroft Z Chen G Dong JB Sunwoo N Yeh C Park C Van Waes Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways Clin Cancer Res 7 2001 435 442
33. PB Mehta BL Jenkins L McCarthy L Thilak CN Robson DE Neal HY Leung MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion Oncogene 22 2003 1381 1389
34. X Wang C Tournier Regulation of cellular functions by the ERK5 signalling pathway Cell Signal 18 2006 753 760
35. S Nishimoto E Nishida MAPK signalling: ERK5 versus ERK1/2 EMBO Rep 7 2006 782 786
36. LL Gleich FN Salamone Molecular genetics of head and neck cancer Cancer Control 9 2002 369 378
37. SM Pupa S Menard S Forti E Tagliabue New insights into the role of extracellular matrix during tumor onset and progression J Cell Physiol 192 2002 259 267
38. Z Chen PS Malhotra GR Thomas FG Ondrey DC Duffey CW Smith I Enamorado NT Yeh GS Kroog S Rudy Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer Clin Cancer Res 5 1999 1369 1379
39. S Derka E Vairaktaris V Papakosta S Vassiliou Y Acil A Vylliotis S Spyridonidou AC Lazaris C Mourouzis A Kokkori Cell proliferation and apoptosis culminate in early stages of oral oncogenesis Oral Oncol 42 2006 540 550
40. LL Loro OK Vintermyr PG Liavaag R Jonsson AC Johannessen Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis Hum Pathol 30 1999 1097 1105
41. BB Singh FW Chandler Jr SB Whitaker AE Forbes-Nelson Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 1998 692 698
42. K Freier S Pungs C Sticht C Flechtenmacher P Lichter S Joos C Hofele High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy Int J Cancer 120 2007 942 946
43. H Kasai D Nadano E Hidaka K Higuchi M Kawakubo TA Sato J Nakayama Differential expression of ribosomal proteins in human normal and neoplastic colorectum J Histochem Cytochem 51 2003 567 574
44. JB Welsh PP Zarrinkar LM Sapinoso SG Kern CA Behling BJ Monk DJ Lockhart RA Burger GM Hampton Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer Proc Natl Acad Sci USA 98 2001 1176 1181
45. E Mendez C Cheng DG Farwell S Ricks SN Agoff ND Futran EA Weymuller Jr NC Maronian LP Zhao C Chen Transcriptional expression profiles of oral squamous cell carcinomas Cancer 95 2002 1482 1494
46. H Peng Y Sohara RA Moats MD Nelson Jr SG Groshen W Ye CP Reynolds YA DeClerck The activity of zoledronic acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation Cancer Res 67 2007 9346 9355
47. YC Henderson MJ Fredrick GL Clayman Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitors Arch Otolaryngol Head Neck Surg 133 2007 810 815
48. A Jinawath Y Akiyama B Sripa Y Yuasa Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells J Cancer Res Clin Oncol 133 2007 271 278
49. CM Schmidt Y Wang C Wiesenauer Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis J Gastrointest Surg 7 2003 1024 1033
50. I Astsaturov RB Cohen P Harari Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer Expert Rev Anticancer Ther 6 2006 1179 1193
51. S Huang EA Armstrong S Benavente P Chinnaiyan PM Harari Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor Cancer Res 64 2004 5355 5362